Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

about

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

P2860

Q42068724-ED7F5BCA-B90B-4ED3-919B-6DB80BE23FCE

P2860

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

Item

http://www.wikidata.org/entity/Q39177686

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@en

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@nl

type

Item

label

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@en

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@nl

prefLabel

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@en

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@nl

P1476

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

@en

P2093

Borek M

http://www.w3.org/2001/XMLSchema#string

Charlap S

http://www.w3.org/2001/XMLSchema#string

Frishman W

http://www.w3.org/2001/XMLSchema#string

P2860

The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects

Comparison of captopril and enalapril in patients with severe chronic heart failure.

Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

A new class of angiotensin-converting enzyme inhibitors.

Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

P304

133-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1875-9114.1987.TB04039.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1987-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2829141

http://www.w3.org/2001/XMLSchema#string

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

about

P2860

P2860

Enalapril: a long-acting angiotensin-converting enzyme inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698